Verywell Health on MSN

Mounjaro vs. Trulicity: How do they compare for type 2 diabetes?

Medically reviewed by Mary Choy, PharmD Key Takeaways Mounjaro often leads to greater reductions in hemoglobin A1C and weight compared to similar medications.Trulicity can help reduce major ...
Seeking Alpha

Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 ...

Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C and weight In the trial, Mounjaro was associated ...